rs1574028

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001394928.1(ITGA6):​c.388-13C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0845 in 1,613,436 control chromosomes in the GnomAD database, including 6,361 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.064 ( 425 hom., cov: 32)
Exomes 𝑓: 0.087 ( 5936 hom. )

Consequence

ITGA6
NM_001394928.1 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.0790

Publications

14 publications found
Variant links:
Genes affected
ITGA6 (HGNC:6142): (integrin subunit alpha 6) The gene encodes a member of the integrin alpha chain family of proteins. Integrins are heterodimeric integral membrane proteins composed of an alpha chain and a beta chain that function in cell surface adhesion and signaling. The encoded preproprotein is proteolytically processed to generate light and heavy chains that comprise the alpha 6 subunit. This subunit may associate with a beta 1 or beta 4 subunit to form an integrin that interacts with extracellular matrix proteins including members of the laminin family. The alpha 6 beta 4 integrin may promote tumorigenesis, while the alpha 6 beta 1 integrin may negatively regulate erbB2/HER2 signaling. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]
ITGA6-AS1 (HGNC:40308): (ITGA6 antisense RNA 1)
PDK1-AS1 (HGNC:40441): (PDK1 and ITGA6 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 2-172469112-C-A is Benign according to our data. Variant chr2-172469112-C-A is described in ClinVar as Benign. ClinVar VariationId is 332358.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.101 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ITGA6NM_001394928.1 linkc.388-13C>A intron_variant Intron 3 of 25 ENST00000442250.6 NP_001381857.1
ITGA6NM_000210.4 linkc.388-13C>A intron_variant Intron 3 of 25 ENST00000684293.1 NP_000201.2 P23229-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ITGA6ENST00000442250.6 linkc.388-13C>A intron_variant Intron 3 of 25 5 NM_001394928.1 ENSP00000406694.1 P23229-1
ITGA6ENST00000684293.1 linkc.388-13C>A intron_variant Intron 3 of 25 NM_000210.4 ENSP00000508249.1 P23229-2

Frequencies

GnomAD3 genomes
AF:
0.0639
AC:
9720
AN:
152102
Hom.:
426
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0189
Gnomad AMI
AF:
0.0187
Gnomad AMR
AF:
0.105
Gnomad ASJ
AF:
0.105
Gnomad EAS
AF:
0.0179
Gnomad SAS
AF:
0.0578
Gnomad FIN
AF:
0.0587
Gnomad MID
AF:
0.0506
Gnomad NFE
AF:
0.0854
Gnomad OTH
AF:
0.0656
GnomAD2 exomes
AF:
0.0786
AC:
19767
AN:
251334
AF XY:
0.0768
show subpopulations
Gnomad AFR exome
AF:
0.0159
Gnomad AMR exome
AF:
0.143
Gnomad ASJ exome
AF:
0.102
Gnomad EAS exome
AF:
0.0156
Gnomad FIN exome
AF:
0.0578
Gnomad NFE exome
AF:
0.0856
Gnomad OTH exome
AF:
0.0746
GnomAD4 exome
AF:
0.0866
AC:
126614
AN:
1461218
Hom.:
5936
Cov.:
32
AF XY:
0.0855
AC XY:
62143
AN XY:
726964
show subpopulations
African (AFR)
AF:
0.0142
AC:
477
AN:
33478
American (AMR)
AF:
0.139
AC:
6236
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.104
AC:
2728
AN:
26124
East Asian (EAS)
AF:
0.0161
AC:
639
AN:
39698
South Asian (SAS)
AF:
0.0588
AC:
5069
AN:
86214
European-Finnish (FIN)
AF:
0.0584
AC:
3117
AN:
53414
Middle Eastern (MID)
AF:
0.0761
AC:
439
AN:
5768
European-Non Finnish (NFE)
AF:
0.0926
AC:
102889
AN:
1111436
Other (OTH)
AF:
0.0832
AC:
5020
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
5328
10656
15983
21311
26639
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3824
7648
11472
15296
19120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0639
AC:
9723
AN:
152218
Hom.:
425
Cov.:
32
AF XY:
0.0630
AC XY:
4686
AN XY:
74424
show subpopulations
African (AFR)
AF:
0.0188
AC:
781
AN:
41530
American (AMR)
AF:
0.105
AC:
1608
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.105
AC:
366
AN:
3472
East Asian (EAS)
AF:
0.0181
AC:
94
AN:
5188
South Asian (SAS)
AF:
0.0571
AC:
275
AN:
4820
European-Finnish (FIN)
AF:
0.0587
AC:
622
AN:
10602
Middle Eastern (MID)
AF:
0.0544
AC:
16
AN:
294
European-Non Finnish (NFE)
AF:
0.0854
AC:
5808
AN:
67996
Other (OTH)
AF:
0.0644
AC:
136
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
458
917
1375
1834
2292
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
118
236
354
472
590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0839
Hom.:
576
Bravo
AF:
0.0672
Asia WGS
AF:
0.0400
AC:
141
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Junctional epidermolysis bullosa with pyloric atresia Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
6.9
DANN
Benign
0.73
PhyloP100
-0.079
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1574028; hg19: chr2-173333840; API